Drug Shortage Report for TEVA-MYCOPHENOLATE

Last updated on 2021-01-14 History
Report ID 119956
Drug Identification Number 02364883
Brand name TEVA-MYCOPHENOLATE
Common or Proper name MYCOPHENOLATE 250MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MYCOPHENOLATE MOFETIL
Strength(s) 250MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size UD 100
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-08-04
Actual start date
Estimated end date 2020-11-30
Actual end date 2021-01-13
Shortage status Resolved
Updated date 2021-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2021-01-14 French Compare
v13 2021-01-14 English Compare
v12 2020-10-15 French Compare
v11 2020-10-15 English Compare
v10 2020-09-10 French Compare
v9 2020-09-10 English Compare
v8 2020-09-03 French Compare
v7 2020-09-03 English Compare
v6 2020-08-05 English Compare
v5 2020-07-23 French Compare
v4 2020-07-23 English Compare
v3 2020-07-10 French Compare
v2 2020-07-10 English Compare
v1 2020-07-10 English Compare

Showing 1 to 14 of 14